Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Bandaram Pharma Packtech Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹
High
₹
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1.16 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 96.60 |
| TTM EPS (₹) | 0.25 |
| P/E Ratio | 101.80 |
| Book Value(₹) | 1.62 |
| PAT Margin (%) | 2.69 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 8.41 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 369.64 | 84.91 |
| Expenses | N/A | N/A |
| PBT | 13.16 | 2.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 9.94 | 1.57 |
About Bandaram Pharma Packtech Ltd.
| Founded | 1993 |
|---|---|
| Managing Director | B Deepak Reddy |
Latest News
Jul
21
2026
Posted on Jul 21st 2026
Beta Drugs - Quaterly Results
A decrease in the sales to Rs. 558.26 millions was observed for the quarter ended June 2026. The sales stood at Rs. 663.25 millions during the similar quarter previous year.Good Net Profit growth of 40.16% reported above the corresponding previous quarter figure of Rs. 42.33 millions to Rs. 59.33 millioins.OP of the company witnessed a marginal growth to 120.23 millions from 104.83 millions in the same quarter last year.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 558.26 | 663.25 | -15.83 | 558.26 | 663.25 | -15.83 | 2254.30 | 2202.00 | 2.38 |
| Other Income | 18.67 | 29.75 | -37.24 | 18.67 | 29.75 | -37.24 | 111.43 | 61.92 | 79.96 |
| PBIDT | 120.23 | 104.83 | 14.69 | 120.23 | 104.83 | 14.69 | 396.87 | 376.08 | 5.53 |
| Interest | 16.01 | 27.88 | -42.58 | 16.01 | 27.88 | -42.58 | 118.07 | 47.56 | 148.25 |
| PBDT | 104.22 | 76.95 | 35.44 | 104.22 | 76.95 | 35.44 | 278.80 | 282.82 | -1.42 |
| Depreciation | 24.85 | 20.38 | 21.93 | 24.85 | 20.38 | 21.93 | 96.69 | 74.42 | 29.92 |
| PBT | 79.37 | 56.57 | 40.30 | 79.37 | 56.57 | 40.30 | 182.11 | 208.40 | -12.62 |
| TAX | 20.04 | 14.24 | 40.73 | 20.04 | 14.24 | 40.73 | 38.77 | 54.08 | -28.31 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 59.33 | 42.33 | 40.16 | 59.33 | 42.33 | 40.16 | 143.34 | 154.32 | -7.12 |
| Equity | 110.86 | 100.95 | 9.82 | 110.86 | 100.95 | 9.82 | 101.37 | 100.95 | 0.42 |
| PBIDTM(%) | 21.54 | 15.81 | 36.26 | 21.54 | 15.81 | 36.26 | 17.61 | 17.08 | 3.08 |
Read More
Jul
21
2026
Posted on Jul 21st 2026
Venus Remedies - Quaterly Results
A decent increase of about 30.39% in the sales to Rs. 1788.00 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 1371.30 millions during the year-ago period.The Total revenue for the quarter ended June 2026 of Rs. 255.30 millions grew by 118.39% from Rs. 116.90 millions.Operating Profit saw a handsome growth to 391.10 millions from 206.50 millions in the quarter ended June 2026.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 1788.00 | 1371.30 | 30.39 | 1788.00 | 1371.30 | 30.39 | 7687.30 | 6444.70 | 19.28 |
| Other Income | 25.50 | 27.20 | -6.25 | 25.50 | 27.20 | -6.25 | 114.60 | 157.70 | -27.33 |
| PBIDT | 391.10 | 206.50 | 89.39 | 391.10 | 206.50 | 89.39 | 1553.70 | 907.70 | 71.17 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 391.10 | 206.50 | 89.39 | 391.10 | 206.50 | 89.39 | 1553.70 | 1006.80 | 54.32 |
| Depreciation | 65.10 | 59.50 | 9.41 | 65.10 | 59.50 | 9.41 | 246.90 | 216.20 | 14.20 |
| PBT | 326.00 | 147.00 | 121.77 | 326.00 | 147.00 | 121.77 | 1306.80 | 790.60 | 65.29 |
| TAX | 70.70 | 30.10 | 134.88 | 70.70 | 30.10 | 134.88 | 313.70 | 265.10 | 18.33 |
| Deferred Tax | -11.30 | -6.90 | 63.77 | -11.30 | -6.90 | 63.77 | -15.20 | 46.50 | -132.69 |
| PAT | 255.30 | 116.90 | 118.39 | 255.30 | 116.90 | 118.39 | 993.10 | 525.50 | 88.98 |
| Equity | 133.70 | 133.70 | 0.00 | 133.70 | 133.70 | 0.00 | 133.70 | 133.70 | 0.00 |
| PBIDTM(%) | 21.87 | 15.06 | 45.26 | 21.87 | 15.06 | 45.26 | 20.21 | 14.08 | 43.50 |
Read More
Jul
20
2026
Posted on Jul 20th 2026
Strides Pharma Science informs about record date
Strides Pharma Science has informed that the 35th Annual General Meeting ('AGM') of the Company will be held on Friday, August 14, 2026 at 12:15 hrs IST through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM'), in compliance with the applicable circulars issued by the Ministry of Corporate Affairs ('MCA') and the Securities and Exchange Board of India ('SEBI'). As intimated earlier, Board of Directors of the Company at their meeting held on May 18, 2026 had recommended a Final Dividend of ₹5/- per equity share of face value ₹10/- each (50%) for the financial year ended March 31, 2026, subject to approval of the shareholders at the ensuing AGM. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, July 31, 2026 as the Record Date for determining the entitlement of shareholders to receive the aforesaid Final Dividend: Final Dividend, if approved by shareholders at the ensuing AGM, shall be paid within 30 days from the date of its declaration, through permissible electronic modes to those shareholders whose bank account details are registered with the Depositories and/ or the Company's Registrar and Share Transfer Agent ('RTA'), subject to deduction of applicable taxes at source. Notice convening the AGM and the Annual Report for FY 2025-26 shall be filed separately with the Stock Exchanges and circulated to the shareholders within the prescribed timelines. The same shall also be made available on the website of the Company at www.strides.com and on the websites of BSE Limited and National Stock Exchange of India.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
20
2026
Posted on Jul 20th 2026
Blue Jet Healthcare informs about press release
Blue Jet Healthcare has informed that the company has been awarded with Silver Medal by EcoVadis for its outstanding sustainability management practices in areas such as Environment, Labor and Human Rights, Ethics and Sustainable Procurement. In this regard, it has attached press release issued by the company.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
20
2026
Posted on Jul 20th 2026
Acutaas Chemicals informs about conference call
Acutaas Chemicals has informed that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, an Earnings Conference Call has been organised on Friday, July 24, 2026 at 4.00 PM (IST) to discuss the Unaudited Financial Results of the Company for the first quarter ended on June 30, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Bandaram Pharma Packtech Ltd. is ₹23.00 as of 2026-07-21.
The market capitalisation of Bandaram Pharma Packtech Ltd. is ₹43.28 as of 2026-07-20.
The 1-year return of Bandaram Pharma Packtech Ltd. is -15.42% as of 2025-07-18.
The P/E ratio of Bandaram Pharma Packtech Ltd. is 101.80 as of 2026-07-21.
The 52-week high and low of Bandaram Pharma Packtech Ltd. are ₹49.70 and ₹20.95, respectively, as of 2026-07-21.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
